Skip to main content
Top
Published in: International Journal of Hematology 3/2018

01-09-2018 | Case Report

CD3+ CD56+ EBER1+ atypical extraosseous plasmacytoma of the nasal cavity

Authors: Yayoi Ando, Akiko Miyagi Maeshima, Suguru Fukuhara, Shinichi Makita, Wataru Munakata, Tatsuya Suzuki, Dai Maruyama, Hirokazu Taniguchi, Koji Izutsu

Published in: International Journal of Hematology | Issue 3/2018

Login to get access

Abstract

We present a case of atypical extraosseous plasmacytoma (EP) with a plasmablastic morphology and CD3+ CD56+ Epstein–Barr virus-encoded RNA-1 (EBER1)+ phenotypes of the nasal cavity. A 51-year-old male attended a local hospital with a tumor located in his left nasal cavity that was histologically diagnosed as extranodal NK/T cell lymphoma, nasal type. We reviewed the specimens and re-biopsied the tumor, and confirmed that the tumor was positive for CD3, CD56, and EBER1; however, the tumor showed a plasmablastic morphology without necrosis and angiocentricity, and was positive for CD138, but negative for CD20 and PAX5. Given a plasmablastic morphology and EBER1 positivity, but a relatively low Ki67 index (30%), we diagnosed the case as atypical EP. The CHOP regimen was administered and complete remission achieved. This case indicated that EP should be considered as a differential diagnosis even when a tumor shows large cell morphology and is positive for CD3, CD56, and EBER1.
Literature
1.
go back to reference Stein H, Harris NL, Campo E. Plasmablastic lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2008. p. 15866. Stein H, Harris NL, Campo E. Plasmablastic lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2008. p. 15866.
2.
go back to reference Teruya-Feldstein J, Chiao E, Filippa DA, Lin O, Comenzo R, Coleman M, et al. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol. 2004;15:1673–9.CrossRefPubMed Teruya-Feldstein J, Chiao E, Filippa DA, Lin O, Comenzo R, Coleman M, et al. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol. 2004;15:1673–9.CrossRefPubMed
3.
go back to reference Al Tabaa Y, Tuaillon E, Bollore K, Foulongne V, Petitjean G, Seigneurin JM, et al. Functional Epstein–Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells. Blood. 2009;113:604–11.CrossRefPubMed Al Tabaa Y, Tuaillon E, Bollore K, Foulongne V, Petitjean G, Seigneurin JM, et al. Functional Epstein–Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells. Blood. 2009;113:604–11.CrossRefPubMed
4.
go back to reference Yan J, Wang J, Zhang W, Chen M, Chen J, Liu W. Solitary plasmacytoma associated with Epstein–Barr virus: a clinicopathologic, cytogenetic study and literature review. Ann Diagn Pathol. 2017;27:1–6.CrossRefPubMed Yan J, Wang J, Zhang W, Chen M, Chen J, Liu W. Solitary plasmacytoma associated with Epstein–Barr virus: a clinicopathologic, cytogenetic study and literature review. Ann Diagn Pathol. 2017;27:1–6.CrossRefPubMed
5.
go back to reference Maeshima AM, Taniguchi H, Makita S, Kitahara H, Miyamoto K, Fukuhara S, et al. Histopathological characteristics of lymphomas in the upper aerodigestive tract. A single-institute study in Japan. J Clin Exp Hematop. 2015;55:7–11.CrossRef Maeshima AM, Taniguchi H, Makita S, Kitahara H, Miyamoto K, Fukuhara S, et al. Histopathological characteristics of lymphomas in the upper aerodigestive tract. A single-institute study in Japan. J Clin Exp Hematop. 2015;55:7–11.CrossRef
6.
go back to reference Morscio J, Dierickx D, Nijs J, Verhoef G, Bittoun E, Vanoeteren X, et al. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases. Am J Surg Pathol. 2014;38:875–86.CrossRefPubMed Morscio J, Dierickx D, Nijs J, Verhoef G, Bittoun E, Vanoeteren X, et al. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases. Am J Surg Pathol. 2014;38:875–86.CrossRefPubMed
7.
go back to reference Liu Q, Ohshima K, Sumie A, Suzushima H, Iwasaki H, Kikuchi M. Nasal CD56 positive small round cell tumors. Differential diagnosis of hematological, neurogenic, and myogenic neoplasms. Virchows Arch. 2001;438:271–9.CrossRefPubMed Liu Q, Ohshima K, Sumie A, Suzushima H, Iwasaki H, Kikuchi M. Nasal CD56 positive small round cell tumors. Differential diagnosis of hematological, neurogenic, and myogenic neoplasms. Virchows Arch. 2001;438:271–9.CrossRefPubMed
9.
go back to reference Oliveira JL, Grogg KL, Macon WR, Dogan A, Feldman AL. Clinicopathologic features of B-cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases. Am J Surg Pathol. 2012;36:1364–70.CrossRefPubMed Oliveira JL, Grogg KL, Macon WR, Dogan A, Feldman AL. Clinicopathologic features of B-cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases. Am J Surg Pathol. 2012;36:1364–70.CrossRefPubMed
10.
go back to reference Luo X, Kuklani R, Bains A. Dual CD3 and CD4 positive plasma cell neoplasm with indistinct morphology: a diagnostic pitfall. Pathology. 2016;48:378–80.CrossRefPubMed Luo X, Kuklani R, Bains A. Dual CD3 and CD4 positive plasma cell neoplasm with indistinct morphology: a diagnostic pitfall. Pathology. 2016;48:378–80.CrossRefPubMed
11.
go back to reference Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E, et al. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol. 2004;124:717–26.CrossRefPubMed Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E, et al. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol. 2004;124:717–26.CrossRefPubMed
12.
go back to reference Saito M, Morioka M, Izumiyama K, Mori A, Irie T, Tanaka M, et al. Epstein–Barr virus-positive ileal extraosseous plasmacytoma containing plasmablastic lymphoma components with CD20-positive lymph node involvement. Int J Gen Med. 2012;5:715–8.CrossRefPubMedPubMedCentral Saito M, Morioka M, Izumiyama K, Mori A, Irie T, Tanaka M, et al. Epstein–Barr virus-positive ileal extraosseous plasmacytoma containing plasmablastic lymphoma components with CD20-positive lymph node involvement. Int J Gen Med. 2012;5:715–8.CrossRefPubMedPubMedCentral
13.
go back to reference Loghavi S, Khoury JD, Medeiros LJ. Epstein–Barr virus-positive plasmacytoma in immunocompetent patients. Histopathology. 2015;67:225–34.CrossRefPubMed Loghavi S, Khoury JD, Medeiros LJ. Epstein–Barr virus-positive plasmacytoma in immunocompetent patients. Histopathology. 2015;67:225–34.CrossRefPubMed
Metadata
Title
CD3+ CD56+ EBER1+ atypical extraosseous plasmacytoma of the nasal cavity
Authors
Yayoi Ando
Akiko Miyagi Maeshima
Suguru Fukuhara
Shinichi Makita
Wataru Munakata
Tatsuya Suzuki
Dai Maruyama
Hirokazu Taniguchi
Koji Izutsu
Publication date
01-09-2018
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2018
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-018-2438-y

Other articles of this Issue 3/2018

International Journal of Hematology 3/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine